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Mycoticaneurysmsconstituteasmall proportionofaorticaneurysms.Endovascular repairofmycotic aneurysmshasbeen applied
with good short-term and midterm results. However, the uncommon aortoenteric ﬁstula formation remains a potentially fatal
complicationwhenrepairingsuchinfectiveaneurysms.Wepresentthecaseofan80-year-oldwomanwiththoracicandabdominal
aortic mycotic aneurysms, which were successfully treated with endografting. However, the patient presented 3 months later
with upper gastrointestinal bleeding secondary to erosion of the thoracic graft into the oesophagus. The patient was treated
conservatively due to the high risk of surgical repair. There is currently little exposure to the management of mycotic aortic
aneurysms. If suspected, imaging of the entire vasculature will aid initial diagnosis and highlight the extent of the disease process,
allowing for eﬃcient management. Aortic endografting for mycotic thoracic aneurysms is a high-risk procedure yet is still an
appropriate intervention. Aortoenteric ﬁstulae pose a rare but severe complication of aortic endografting in this setting.
1.Introduction
Almost all clinicians at some point in their career will have
come across a patient with an aortic aneurysm. However,
infectious or mycotic aneurysms only account for a mere 1–
3% of all aortic aneurysms [1]. Their nonspeciﬁc presenta-
tion of fever, malaise, and leukocytosis, poses a particular
challenge to diagnosis and management, which is further
compounded by the underlying infectious process [2].
Thegoldstandardmanagementstrategyremainssurgical
resection and debridement of the infected aorta and the
surrounding tissues, the use of muscle ﬂaps or omentum
to cover the infected ﬁeld and either an interposition graft
or extra-anatomical bypass can be followed by long-term
antibiotic therapy [3]. However, such surgical management
in these patients possesses high surgical risk and mortality
[3]. Moreover, most patients with mycotic aneurysms have
high signiﬁcant comorbidities, resulting in a lethal risk
from major surgery. With the increased application of
aortic endografting, there is an increasing conﬁdence for
its use in the treatment of both degenerative and mycotic
aneurysms. However, there is limited evidence investigating
the eﬀectiveness of aortic endografting in managing mycotic
aneurysms due to scarcity of this disease [2].
Secondary aortoenteric ﬁstula (AEF) is a rare but well-
known complication after open abdominal aortic aneurysm
(AAA) repair, occurring in 0.4–1.6% of cases [4]. It has been
also rarely reported following aortic endografting. Chenu et
al. [5] have reviewed the 16 reported cases of aortoenteric
ﬁstulae after aortic endografting; infection and local inﬂam-
mation were found to be the most acceptable mechanism
underlyingﬁstulaformation.ThereviewconcludedthatAEF
postaortic endografting is diﬃcult to diagnose and treat.
We describe the case of a patient with an aortooe-
sophageal ﬁstula secondary to erosion of endovascular stent
deployed for a mycotic thoracic aneurysm.
2.CaseReport
An 80-year-old lady presented to the emergency depart-
ment with haematemesis, melaena, and back pain of 1-day
duration. Previously, she had undergone aortic endografting
procedures for an abdominal and a thoracic mycotic aortic2 International Journal of Vascular Medicine
aneurysm (4 months and 3 months, resp.). Her past medical
history included stage A chronic lymphoblastic leukaemia
(CLL) diagnosed 12 years ago which was under surveillance
with no current active treatment.
She was referred originally (4 months previously) to the
vascular team with persistent abdominal pain and a palpable
pulsatile mass. She denied any other symptoms, had not
recently lost weight, or had a temperature and urine culture
negative on admission. A chest radiograph at that time
did not report any abnormality. An abdominal computed
tomography (CT) angiogram revealed a saccular AAA, well
below the renal arteries, 4cm in diameter and 3.7cm in
length with inﬂammatory changes suggestive of periaortitis
(Figure 1) .T h ep r e s e n c eo fs u c hi n ﬂ a m m a t o r yc h a n g e sa s
well as high inﬂammatory markers (white blood cell (WBC)
count: 30.2 × 109/L, erythrocyte sedimentation rate (ESR):
120mm/hr) raised a suspicion of a mycotic abdominal
aneurysm. Blood cultures were obtained but did not grow
any microorganisms. It was decided the patient was not ﬁt
enough to undergo an open resection and aneurysm repair.
After discussion with the patient that curative surgery was
likely to prove fatal, she decided to undergo a palliative aortic
endografting using Zenith stent-graft (Cook Incorporated,
Bloomington, Ind).
Subsequently, she was readmitted 2 weeks later with
chest pain, and a chest CT scan revealed another mycotic
aneurysm, this time in the descending thoracic aorta. This
aneurysm was 6cm in diameter, 8.5cm long, and com-
pressing the oesophagus anteriorly (Figure 2). The diagnosis
was again discussed with the patient, and, for symptomatic
control a further endovascular repair utilising Zenith TX2
stent-graft (Cook Incorporated, Bloomington, Ind) was
successfully undertaken and the patient, had an uneventful
immediate postoperative recovery.
Shewasputonlong-termantibioticstopreventrecurrent
septicaemia. Investigations were carried out for other septic
foci, including an echocardiogram; however, nothing was
demonstrated and blood cultures always remained negative.
Her last surveillance CT angiogram was 3 months after
her original admission and demonstrated both stents to be
well positioned without any evidence of extraluminal leak.
At the time of current admission (4 months after she
initially presented), the patient had haematemesis, meleana,
and back pain. Initial investigations showed haemoglobin of
6.5g/dL,WBCcountof13.8×109/L(neutrophils4.6×109/L,
lymphocytes 8.7 × 109/L), Urea 6.8mmol/L, and creatinine
70umol/L. Emergency esophagogastroscopy revealed ero-
sion of the thoracic aortic stent into the oesophagus with
active bleeding (Figure 3). The bleeding points were injected
with adrenaline with good eﬀect.
An urgent multidisciplinary team meeting including a
consultant vascular surgeon, consultant vascular radiologist,
consultant gastroenterologist, and consultant haematologist
agreed that any further operative treatment was likely to
prove fatal. The patient and her family were informed of
this advice, and, after further discussion, the decision was
made to proceed with active supportive medical treatment,
including intravenous omeprazole and blood transfusion,
b u tn of u r t h e rs u r g i c a lp r o c e d u r e sw e r ec o n t e m p l a t e d .
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Figure 1: CT scan of the abdominal aorta demonstrating a mycotic
aneurysm below the renal arteries.
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Figure 2: CT scan of the thoracic aorta demonstrating a mycotic
aneurysm in the descending thoracic aorta.
Figure 3: Esophagogastroscopy showing bleeding in the mid
oesophagus with the aortic stent eroding into the oesophagus.International Journal of Vascular Medicine 3
Theladywastransferredtohospicecareonanalgesia,and
regular antibiotics and she died 33 days later due to general
deterioration and sepsis.
3. Discussion
Mycotic aortic aneurysms account for only 1–3% [1]o fa l l
aortic aneurysms and can occur in previously normal aorta
although the presence of an aneurysm does predispose to a
mycotic aneurysm [6].Anyarteriallesion,includinginfective
endocarditis, can also be considered a causative factor of a
mycotic aneurysm. Risk factors, rather than direct causative
elements, include immunosuppression, intravenous drug
use, and septicaemia [7] .T h er e l a t i v er a r i t ya n dp r e f e r e n c e
for the thoracic portion of the aorta of mycotic aneurysms
increases the complexity of their management [2]. This is
further complicated by the fact that the ﬁrst presentation
is often with aneurysmal rupture, which is unfortunately
associated with lethal consequences [2, 6].
In this case report, the initial radiological investigation
was a CT angiogram of the abdominal aorta, which diag-
nosed the infrarenal mycotic aneurysm. A chest radiograph
at that time did not report any abnormality. However, within
a few weeks, she represented with symptoms warranting a
CT thorax, and subsequently the thoracic aneurysm was
diagnosed. It is unclear as to whether she had developed
this pathology in her postoperative phase, or whether
it was indeed present prior to/at the same time as the
abdominal aortic aneurysm. It has been shown that mycotic
aneurysms are often multiple and have a predilection to
aﬀectthethoracicaortaandthevisceralsegments[2].Hence,
we propose that one should consider scanning the entire
vascular system whenever a mycotic aneurysm is diagnosed
to exclude further infected segments.
The “classic” presentation of AEF involves Chiari’s triad
of aortoesophageal syndrome—chest pain, episode of small
haematemesis followed by massive Haematemesis [6]. AEF
is a severe, life-threatening condition with a high morbidity
and mortality [8]. The deﬁnitive management of this condi-
tionisopensurgicalcorrectionoftheﬁstulaandoesophageal
repair. However, in some cases, thoracic endovascular aortic
aneurysm repair has been shown to serve as a bridge to
surgery, allowing patient optimisation [8–10].
Aortic endografting is now a well-established mode of
treatment for aortic aneurysms. It has been used in many
cases of mycotic aneurysm with mixed results. The concept
of deploying a prosthetic graft into the site of infection
is indeed controversial [1–3, 5]. Clough et al. [2]f o u n d
that aortic endografting for mycotic aneurysm is a feasible
procedure,withconcomitantantibiotictherapycrucialtothe
management.However,despiteantibioticuse,therewerestill
concerns over ongoing infection, as demonstrated with this
case.
Like any intervention, aortic endografting does not
come without complications, most commonly postoperative
infection, endoleak, graft migration, aortic rupture, aortic
thrombosis, and endotension. AEF as a complication of
thoracic aortic endografting is rare and has an extremely
poor prognosis. There are many aetiologies, leading to the
formation of such ﬁstulae, the most common being aortic
wall erosion by the stent.
This is postulated to be due to progressive erosion
through the oesophageal and aortic walls by the rigid
extremities of the stent itself [5, 7]. Furthermore, infection
and local inﬂammation alone are common and recognised
causativefactorsforAEF[5].Thus,thecombinationofaortic
endografting in the light of a mycotic aneurysm may further
increase the risk of AEF in these patients [5].
4. Conclusion
Mycotic thoracic aneurysms are rare, and there is currently
little exposure to their management. If suspected, imaging
of the entire aorta will aid initial diagnosis and highlight
the extent of the disease process, allowing for eﬃcient
management.
Aortic endografting for mycotic thoracic aneurysms is a
high-risk procedure yet is still an appropriate intervention,
althoughnotadeﬁnitivetreatmentandshouldbeconsidered
a temporising measure. It allows for further discussion
with the patient and family, the option to further plan
open operative resection and repair and provides some
symptomatic control. The use of antibiotics concomitantly
remains essential to the management of mycotic aneurysms.
Aortoenteric ﬁstulae pose a rare yet severe complication
of aortic endografting, and awareness of this as a potential
complication is crucial for early recognition and subsequent
management. As this case study shows, a greater than 30-
day survival is possible despite severe postoperative compli-
cations and following diagnosis of AEF.
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